# Parathyroid histology in normocalcemic and hypercalcemic primary hyperparathyroidism with hypercalciuric renal stones

**Authors:** Bénédicte Blanchard, Safia Hadjadj, Ellie Tang, Jennifer Kervadec, Souhila Ouchelouche, Perrine Frere, Olivier Traxer, Isabelle Wagner, Diane Evrard, Pierre Riebler, David Buob, Emmanuel Letavernier, Jean-Philippe Haymann, Caroline Halimi

PMC · DOI: 10.1210/jendso/bvag014 · Journal of the Endocrine Society · 2026-02-23

## TL;DR

This study compares the histological features of two types of primary hyperparathyroidism, focusing on calcium and vitamin D-related markers in parathyroid glands.

## Contribution

The study identifies distinct histological and immunohistochemical patterns between normocalcemic and hypercalcemic primary hyperparathyroidism.

## Key findings

- Hypercalcemic primary hyperparathyroidism shows decreased CaSR and increased CYP27B1/VDR in chief cells.
- Normocalcemic primary hyperparathyroidism shows decreased VDR in oxyphil cells and normal CaSR/CYP27B1.
- A rim of normal tissue is more frequent in hypercalcemic primary hyperparathyroidism.

## Abstract

Hypercalcemic (HPHPT) and normocalcemic primary hyperparathyroidism (NHPT) are distinct conditions with different biological and histological characteristics. Understanding their histological patterns could improve disease characterization.

This study aimed to compare the histological features of NHPT and HPHPT parathyroid glands, but also rims of normal tissue, focusing on the expression of calcium-sensing receptor (CaSR), 1-α hydroxylase (CYP27B1), and vitamin D receptor (VDR).

A retrospective observational study was conducted on histological and immunohistochemical data from parathyroid gland samples. The study included 50 hypercalciuric renal stone patients, of whom 18 had NHPT and 32 had HPHPT. Histological and immunohistochemical analyses were performed to evaluate cell distribution and marker expression. Parathyroid gland weight, cell distribution, and CaSR, CYP27B1, and VDR expression were analyzed and compared between NHPT, HPHPT, and rim biopsies.

Parathyroid gland weight and cell distribution were similar in both groups. A rim of normal tissue was more frequent in HPHPT (69% vs 37%; P = .02). In HPHPT, CaSR expression was decreased, while CYP27B1 and VDR expressions were increased in chief cells compared to rim tissue (P = .005, .004, and <.001, respectively). NHPT showed no CaSR or CYP27B1 alterations but a decreased VDR expression in oxyphil cells compared to HPHPT (P = .02).

The NHPT hallmark phenotype is normal CaSR, CYP27B1/VDR expression in chief cells, with decreased VDR expression in oxyphil cells. HPHPT chief cell patterns show a marked CaSR decreased expression along with an increased CYP27B1/VDR expression, suggesting an appropriate autocrine/paracrine counterregulation to hypercalcemia/high PTH.

## Linked entities

- **Genes:** CASR (calcium sensing receptor) [NCBI Gene 846], CYP27B1 (cytochrome P450 family 27 subfamily B member 1) [NCBI Gene 1594], VDR (vitamin D receptor) [NCBI Gene 7421]
- **Diseases:** primary hyperparathyroidism (MONDO:0010837)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, CASR (calcium sensing receptor) [NCBI Gene 846] {aka CAR, EIG8, FHH, FIH, GPRC2A, HHC}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, CYP27B1 (cytochrome P450 family 27 subfamily B member 1) [NCBI Gene 1594] {aka CP2B, CYP1, CYP1alpha, CYP27B, P450c1, PDDR}
- **Diseases:** NHPT (MESH:D049950), hypercalciuric renal stone (MESH:D007669), hypercalcemia (MESH:D006934)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026408/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13026408/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026408/full.md

---
Source: https://tomesphere.com/paper/PMC13026408